Stockreport

Gene Editing Korro Bio's Preclinical Data 'Best-In-Class', Analyst Initiates With Outperform Rating [Yahoo! Finance]

Wave Life Sciences Ltd. - Ordinary Shares  (WVE) 
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am Check Earnings Report
PDF The company's proprietary Oligonucleotide Promoted Editing of RNA (OPERA) platform harnesses the body's natural base editing system – specifically ADAR (Adenosine Deami [Read more]